Commercialisation of nanomaterials: process, issues, and management

7 June 2017, London, United Kingdom


Introduction
A joint one-day meeting between RSC Toxicology group and the UK NanoSafety Group.  This meeting is looking to provide information and examples of best practice in the successful and safe commercialisation of nanomaterial based products. Those who should attend include: safety professionals, compliance managers, plant managers, general managers and those working with nanomaterials in industry or have an interest in the safe production of nanomaterial based products and services. It is also looking to attract academics who may be seeking to “go commercial” with a nano based product. 

Speakers include:

Eric Mayes, Endomagnetics
"Taking a nano-based medical product to the international market"
Charles Clifford, National Physical Laboratory​
"Standards and their value in general and specifically for nanotechnology"
Kay Williams, Defra 
"Nanomaterials – planning for EU exit"
Colin Johnston​, OMCS
"Value of effective testing of nano based products"
Iseult Lynch, University of Birmingham
"Comments and conclusions re what’s safe and what’s not – past and future"
Claire Skentelbery, Nanotechnology Industries Association​
“What’s happening commercially in Europe”​
Barry Park​, GBP Consulting Ltd​
"Commercial applications of nanoparticles​"
Pete Gooden, Promethean Particles
“Commissioning a new plant to produce nanomaterials commercially”​
Venue
The Royal Society of Chemistry

The Royal Society of Chemistry, Burlington House, Piccadilly, London, W1J 0BA, United Kingdom

Organised by
Contact information
Search
 
 
Showing all upcoming events
Start Date
End Date
Location
Subject area
Event type

Advertisement Spotlight Advertisement

E-mail Enquiry
*
*
*
*